Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1279524 | 0.83 | — | — | |
| SCHEMBL17424784 | 0.74 | — | — | |
| Perfluorocyclobutane SCHEMBL28018597 | 0.69 | MEN1 (0.46) | MEN1KMT2ATDP1 | |
| SCHEMBL11096575 | 0.67 | MEN1 (0.36) | MEN1KMT2ATDP1 | |
| SCHEMBL8956010 | 0.65 | — | — | |
| SCHEMBL10354579 | 0.64 | MEN1 (0.33) | MEN1KMT2ATDP1 | |
| SCHEMBL37587 | 0.64 | MEN1 (0.33) | MEN1KMT2ATDP1 | |
| SCHEMBL554739 | 0.64 | MEN1 (0.33) | MEN1KMT2ATDP1 | |
| SCHEMBL196722 | 0.64 | MEN1 (0.33) | MEN1KMT2ATDP1 | |
| SCHEMBL15186 | 0.64 | MEN1 (0.33) | MEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2309849-B1 | METHOD OF TREATING TRAUMATIC BRAIN INJURY | TENAX THERAPEUTICS INC (US) | 2015-09-02 | — | — | EP | claimed |
| EP-2459235-B1 | PERFLUORO-T-BUTYL CYCLOHEXANE FOR USE IN IMAGING | KONINKL PHILIPS NV (NL) | 2014-04-23 | — | — | EP | claimed |
| US-20130289471-A1 | GAS BASED WOUND AND TISSUE THERAPEUTICS | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2013-10-31 | — | — | US | claimed |
| US-8404752-B2 | Method of treating traumatic brain injury | OXYGEN BIOTHERAPEUTICS, INC. (US) | 2013-03-26 | — | — | US | claimed |
| US-20120184898-A1 | GAS BASED WOUND AND TISSUE THERAPEUTICS | TENAX THERAPEUTICS, INC | 2012-07-19 | — | — | US | claimed |
| EP-2459235-A2 | PERFLUORO COMPOUNDS FOR USE IN IMAGING | Koninklijke Philips Electronics N.V. (NL) | 2012-06-06 | — | — | EP | claimed |
| US-20120128589-A1 | Perfluoro Compounds For Use In Imaging | KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) | 2012-05-24 | — | — | US | claimed |
| US-20110229575-A1 | DEEP IMMERSION FLOTATION THERAPY FOR BURN VICTIMS | TENAX THERAPEUTICS, INC | 2011-09-22 | — | — | US | claimed |
| EP-2309849-A1 | METHOD OF TREATING TRAUMATIC BRAIN INJURY | Oxygen Biotherapeutics, Inc. (US) | 2011-04-20 | — | — | EP | claimed |
| WO-2011013038-A2 | PERFLUORO COMPOUNDS FOR USE IN IMAGING | KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) | 2011-02-03 | — | — | WO | claimed |
| EP-2252333-A2 | GAS BASED WOUND AND TISSUE THERAPEUTICS | Oxygen Biotherapeutics, Inc. (US) | 2010-11-24 | — | — | EP | claimed |
| US-20100178347-A1 | Method of treating traumatic brain injury | TENAX THERAPEUTICS, INC | 2010-07-15 | — | — | US | claimed |
| WO-2010033187-A1 | DEEP IMMERSION FLOTATION THERAPY FOR BURN VICTIMS | OXYGEN BIOTHERAPEUTICS, INC. (US) | 2010-03-25 | — | — | WO | claimed |
| WO-2010008594-A1 | METHOD OF TREATING TRAUMATIC BRAIN INJURY | OXYGEN BIOTHERAPEUTICS, INC. (US) | 2010-01-21 | — | — | WO | claimed |
| WO-2009102487-A2 | GAS BASED WOUND AND TISSUE THERAPEUTICS | OXYGEN BIOTHERAPEUTICS, INC. (US) | 2009-08-20 | — | — | WO | claimed |
| US-20090202617-A1 | Gas based wound and tissue therapeutics | TENAX THERAPEUTICS, INC | 2009-08-13 | — | — | US | claimed |
| CN-116035949-B | Oil balance type low-turbidity high-compatibility cosmetic composition | 广州科创材料科技有限公司 | 2025-02-07 | — | — | CN | disclosed |
| US-20240217902-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2024-07-04 | — | — | US | disclosed |
| EP-2024287-A1 | METHODS AND COMPOSITIONS FOR CONTROLLED AND SUSTAINED PRODUCTION AND DELIVERY OF PEROXIDES | Virginia Commonwealth University (US) | 2009-02-18 | — | — | EP | disclosed |
| WO-2007134304-A1 | METHODS AND COMPOSITIONS FOR CONTROLLED AND SUSTAINED PRODUCTION AND DELIVERY OF PEROXIDES | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2007-11-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110229575-A1 | DEEP IMMERSION FLOTATION THERAPY FOR BURN VICTIMS | HSP90AB1, FLOT1, HSP90AA1 | MEN1 4885/4885KMT2A 3522/4885TDP1 1516/4885 |
| US-20240217902-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | EMC1, EMC2, AOC1 | MEN1 2685/4885KMT2A 847/4885TDP1 3117/4885 |
| US-20120128589-A1 | Perfluoro Compounds For Use In Imaging | FABP7, PHOSPHO1, FABP1 | MEN1 1217/4885KMT2A 4078/4885TDP1 1750/4885 |
| US-20090202617-A1 | Gas based wound and tissue therapeutics | PGF, FGF2, FGF1 | MEN1 4828/4885KMT2A 3572/4885TDP1 3589/4885 |
| US-20100178347-A1 | Method of treating traumatic brain injury | FABP7, PMP22, NEFM | MEN1 3583/4885KMT2A 2822/4885TDP1 667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.